ATE497978T1 - Pharmazeutische zusammensetzungen von antikörpern von viruserkrankungen - Google Patents
Pharmazeutische zusammensetzungen von antikörpern von viruserkrankungenInfo
- Publication number
- ATE497978T1 ATE497978T1 AT08447031T AT08447031T ATE497978T1 AT E497978 T1 ATE497978 T1 AT E497978T1 AT 08447031 T AT08447031 T AT 08447031T AT 08447031 T AT08447031 T AT 08447031T AT E497978 T1 ATE497978 T1 AT E497978T1
- Authority
- AT
- Austria
- Prior art keywords
- antibodies
- pharmaceutical compositions
- virus diseases
- interferon gamma
- peptide sequence
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08447031A EP2138513B1 (de) | 2008-06-27 | 2008-06-27 | Pharmazeutische Zusammensetzungen von Antikörpern von Viruserkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE497978T1 true ATE497978T1 (de) | 2011-02-15 |
Family
ID=40032474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08447031T ATE497978T1 (de) | 2008-06-27 | 2008-06-27 | Pharmazeutische zusammensetzungen von antikörpern von viruserkrankungen |
Country Status (8)
Country | Link |
---|---|
US (1) | US9409991B2 (de) |
EP (1) | EP2138513B1 (de) |
CN (1) | CN102216330B (de) |
AT (1) | ATE497978T1 (de) |
CA (1) | CA2729226C (de) |
DE (1) | DE602008004898D1 (de) |
ES (1) | ES2360334T3 (de) |
WO (1) | WO2009155670A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2766386A1 (de) * | 2011-10-12 | 2014-08-20 | Alpha-o Peptides AG | Selbstanordnende peptid-nanoteilchen als impfstoffe gegen eine norovirus-infektion |
US10574712B2 (en) | 2016-02-19 | 2020-02-25 | International Business Machines Corporation | Provisioning conference rooms |
WO2022031871A1 (en) * | 2020-08-05 | 2022-02-10 | Synthekine, Inc. | Compositions and methods related to il27 receptor binding |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005847A1 (en) * | 1993-08-20 | 1995-03-02 | University Of Medicine & Dentistry Of New Jersey | Accessory factor function for interferon gamma and its receptor |
RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
US7115264B2 (en) | 2001-11-05 | 2006-10-03 | Inhibitex | Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections |
AU2003234443A1 (en) | 2002-05-01 | 2003-11-17 | Beth Israel Deaconess Medical Center | Use of anti-cd1 antibodies for the modulation of immune responses |
JP2004016021A (ja) * | 2002-06-12 | 2004-01-22 | Japan Science & Technology Corp | 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット |
UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
AU2003302235A1 (en) | 2002-12-03 | 2004-06-23 | Sloan-Kettering Institute For Cancer Research | Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
JP2006517191A (ja) * | 2002-12-30 | 2006-07-20 | アムジエン・インコーポレーテツド | 共刺激因子を用いた併用療法 |
US20050136103A1 (en) | 2003-09-17 | 2005-06-23 | Ben-Sasson Shmuel A. | Compositions capable of facilitating penetration across a biological barrier |
WO2006054129A1 (en) * | 2004-11-19 | 2006-05-26 | Institut Gustave Roussy | Improved treatment of cancer by double-stranded rna |
AR051836A1 (es) * | 2004-11-30 | 2007-02-14 | Centocor Inc | Antagonistas de receptor 3 simil toll metodos y usos |
CN101151277B (zh) * | 2005-01-27 | 2013-11-13 | 诺维莫尼公司 | 抗干扰素γ抗体及其使用方法 |
ES2435775T3 (es) * | 2005-10-27 | 2013-12-23 | Janssen Biotech, Inc. | Moduladores de receptor tipo Toll 3, procedimientos y usos |
US20090068684A1 (en) * | 2007-03-26 | 2009-03-12 | Cell Signaling Technology, Inc. | Serine and threoninephosphorylation sites |
-
2008
- 2008-06-27 EP EP08447031A patent/EP2138513B1/de not_active Not-in-force
- 2008-06-27 DE DE602008004898T patent/DE602008004898D1/de active Active
- 2008-06-27 ES ES08447031T patent/ES2360334T3/es active Active
- 2008-06-27 AT AT08447031T patent/ATE497978T1/de not_active IP Right Cessation
-
2009
- 2009-06-26 WO PCT/BE2009/000035 patent/WO2009155670A2/en active Application Filing
- 2009-06-26 US US13/001,498 patent/US9409991B2/en active Active
- 2009-06-26 CA CA2729226A patent/CA2729226C/en not_active Expired - Fee Related
- 2009-06-26 CN CN200980127882.5A patent/CN102216330B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2009155670A3 (en) | 2010-04-01 |
ES2360334T3 (es) | 2011-06-03 |
EP2138513B1 (de) | 2011-02-09 |
DE602008004898D1 (de) | 2011-03-24 |
WO2009155670A2 (en) | 2009-12-30 |
US9409991B2 (en) | 2016-08-09 |
CN102216330B (zh) | 2014-04-16 |
CA2729226C (en) | 2016-08-16 |
EP2138513A1 (de) | 2009-12-30 |
CN102216330A (zh) | 2011-10-12 |
US20110177081A1 (en) | 2011-07-21 |
CA2729226A1 (en) | 2009-12-30 |
WO2009155670A8 (en) | 2011-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6290682A2 (es) | Compuestos triciclicos fusionados inhibidores del virus de la hepatitis c. | |
BR112012011100A2 (pt) | compostos inibidores do vírus da hepatite, composição e uso dos mesmos | |
CL2009000305A1 (es) | Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv). | |
CY1115253T1 (el) | Κρυσταλλικες μορφες ενος παραγωγου 2-θειαζολυλο-4-κινολινυλ-οξυ-ομαδας, ενος ισχυρου αναστολεα του ηcv | |
CL2009002206A1 (es) | Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales. | |
MX2010001733A (es) | Compustos de imidazo[1,2-a]pirazina para tratamiento de infecciones virales tales como hepatitis. | |
EP2078083A4 (de) | Neues hundeinfluenza-virus und imfpstoff hierfür | |
SV2005001920A (es) | " compuestos nucleosidos para el tratamiento de infecciones virales " | |
CL2008001005A1 (es) | Compuestos derivados de azufre, inhibidores de la serina proteasa ns3 del virus de la hepatitis c; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos asociados a la proteasa de hcv. | |
BR112013020042A2 (pt) | inibidores de vírus da hepatite c | |
BR122021002201A8 (pt) | Composto, composição, uso de um composto, e, método de tratamento de um distúrbio, condição ou doença | |
BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
EA200970916A1 (ru) | Соединения 5,6-дигидро-1н-пиридин-2-она | |
BR112014004860A2 (pt) | composições de anticorpo contra vírus da influenza | |
BRPI0906710B8 (pt) | peptídeo derivado de pres modificado hidrofóbico de vírus da hepatite b (hbv) , peptídeo e composição farmacêutica | |
EA200802247A1 (ru) | Схема дозирования кладрибина для лечения рассеянного склероза | |
BR112013002729A2 (pt) | inibidores de vírus de hepatite c | |
NI201100076A (es) | Péptidos antivirales terapéuticos. | |
DK2186830T3 (da) | Polyethylenglycol modificeret interferon alpha 2B og fremstillingsfremgangsmåde og applikationer deraf | |
UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
CY1118399T1 (el) | Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c | |
UY31685A (es) | Compuestos antivirales, composiciones y metodos para usarlos | |
BRPI0511466A (pt) | agonistas peptìdicos do receptor de vasopressina | |
ES2530670T3 (es) | Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo | |
EA201170605A1 (ru) | Циклоундекадепсипептидные соединения и применение указанных соединений в качестве лекарственного средства |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |